Exhibit 107
Calculation of Filing Fee Tables
S-1
(Form Type)
TransCode Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price(1) |
Fee Rate | Amount of Registration Fee |
|||||||||||||||||||
| Fees to be Paid | Equity | Common stock, $0.0001 par value per share | 457(g) | — | — | $ | 2,152,704 | 0.00015310 | $ | 329.58 | ||||||||||||||||
| Fees to be Paid | Equity | Common stock underlying the Pre-Funded Warrants | 457(g) | — | — | 5,847,357 | $ | 0.00015310 | $ | 895.23 | ||||||||||||||||
| Fees to be Paid | Equity | Common stock underlying the Series C Warrants(2) | 457(g) | — | — | $ | 10,079,576 | $ | 0.00015310 | $ | 1,543.18 | |||||||||||||||
| Fees to be Paid | Equity | Common stock underlying the Series D Warrants(3) | 457(g) | — | — | $ | 30,238,729 | $ | 0.00015310 | $ | 4,629.55 | |||||||||||||||
| Fees Previously Paid | — | — | — | — | — | — | — | $ | — | |||||||||||||||||
| Carry Forward Securities | — | — | — | — | — | — | — | — | ||||||||||||||||||
| Total Offering Amounts | $ | 48,318,366 | $ | 7,397.54 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||||
| Total Fee Offset | — | |||||||||||||||||||||||||
| Net Fee Due | $ | 7,397.54 | ||||||||||||||||||||||||
| (1) | Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. |
| (2) | The maximum aggregate offering price of the Series C Warrants were calculated using the Floor Price per warrant. |
| (3) | The maximum aggregate offering price of the Series D Warrants were calculated using the Floor Price per warrant. |